2021-11-12 07:10:00
SAMRAT PHARMA's 2x capacity expansion is getting completed.
H2 onwards, financials will take quantum leap.
Samrat pharma: Cheapest Pharma StockKing of iodine
Samrat pharma engaged in the manufacture of iodine derivatives.
The applications of these derivatives include Pharma, fertilisers, food, salt, etc. SPL has increased its product range catering to various industrial segments of FMCG, Animal Feed, and Agrochemicals among others.
Company has reported consistent growth in the last 5 quarters
Consistent growth with improvement in margins (Revenue has increase 80% over last 4 quarters with profit up 338%)
Fundamentally undervalued: Trading at throwaway valuations
Expansion plans on course (Sources: Analyst meet with MD posted in ET)
ROCE: 22.43%
Cash Reserves 23 cr
Cash Equivalents 5.82 Cr
8.9K views04:10